International Patent: ANTLCYCLIN SINGLE DOMAIN ANTIBODIES, NANO-CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

GENEVA, Sept. 24 -- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM filed a patent application (US2026/019594) for “ANTLCYCLIN SINGLE DOMAIN ANTIBODIES, NANO-CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF”. With publication no. WO/2026/198571, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/395

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....